October is Rett Syndrome Awareness Month, and the International Rett Syndrome Foundation (IRSF) is encouraging people to go “All In”…
Articles by Andrea Lobo, PhD
Taysha Gene Therapies, which is developing TSHA-102 as a potential Rett syndrome treatment, raised $150 million in…
Individuals with Rett syndrome experience a “substantial” clinical and economic burden throughout their life, according to a new real-world…
The Rett Syndrome Research Trust (RSRT) has granted $1.1 million to help advance the development of the Emerald biosensor…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Ketarx (racemic ketamine) for treating…
The Rett Syndrome Research Trust (RSRT) is supporting ongoing studies of HRP-12975, an investigational therapy for Rett syndrome,…
A study on the brain’s molecular anomalies in Rett Syndrome received $100,000 in funding from the Canadian Institutes of…